Home Other Building Blocks adiphenine

adiphenine

CAS No.:
64-95-9
Catalog Number:
AG00EDNA
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00EDNA
Chemical Name:
adiphenine
CAS Number:
64-95-9
MDL Number:
MFCD00242658
IUPAC Name:
2-(diethylamino)ethyl 2,2-diphenylacetate
InChI:
InChI=1S/C20H25NO2/c1-3-21(4-2)15-16-23-20(22)19(17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,19H,3-4,15-16H2,1-2H3
InChI Key:
JGOAIQNSOGZNBX-UHFFFAOYSA-N
EC Number:
200-599-0
UNII:
YKG6OR043Q
Properties
Complexity:
311  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
311.189g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
311.425g/mol
Monoisotopic Mass:
311.189g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
29.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.2  
Literature
Title Journal
Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. Toxicology letters 20150105
Shape-based reprofiling of FDA-approved drugs for the H₁ histamine receptor. Journal of medicinal chemistry 20120823
Antidepressants and advertising: psychopharmaceuticals in crisis. The Yale journal of biology and medicine 20120301
Hypotensive bradycardic events during shoulder arthroscopic surgery under interscalene brachial plexus blocks. Korean journal of anesthesiology 20120301
Challenging medical ghostwriting in US courts. PLoS medicine 20120101
A community-integrated home based depression intervention for older African Americans: [corrected] description of the Beat the Blues randomized trial and intervention costs. BMC geriatrics 20120101
[Investigation of the Hounsfield number of drugs in stomach using computed tomography in vitro]. Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology 20110901
Legal remedies for medical ghostwriting: imposing fraud liability on guest authors of ghostwritten articles. PLoS medicine 20110801
Comparison of recurrence rate based on the frequency of preceding symptoms in patients with neurocardiogenic syncope or presyncope. Korean circulation journal 20110801
Paxil study under fire. Nature 20110712
Using time-series intervention analysis to understand U.S. Medicaid expenditures on antidepressant agents. Research in social & administrative pharmacy : RSAP 20110301
The creation of the health consumer: challenges on health sector regulation after managed care era. Globalization and health 20110101
Postdischarge impact of C-L psychiatry treatment in obstetrical inpatients. ISRN obstetrics and gynecology 20110101
The chemical basis of pharmacology. Biochemistry 20101207
The haunting of medical journals: how ghostwriting sold 'HRT'. PLoS medicine 20100901
Negotiating the boundary between medicine and consumer culture: online marketing of nutrigenetic tests. Social science & medicine (1982) 20100301
Could chiropractors screen for adverse drug events in the community? Survey of US chiropractors. Chiropractic & osteopathy 20100101
Of sophists and spin-doctors: industry-sponsored ghostwriting and the crisis of academic medicine. Mens sana monographs 20100101
Adverse drug effects in hospitalized elderly: data from the healthcare cost and utilization project. Clinical pharmacology : advances and applications 20100101
Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20090901
The local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms. British journal of pharmacology 20090701
Sequestered evidence and the distortion of clinical practice guidelines. Perspectives in biology and medicine 20090101
Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs. Harm reduction journal 20090101
Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy. Core evidence 20090101
(3S,4R)-4-(4-Fluoro-phen-yl)-3-(hydroxy-meth-yl)piperidinium chloride. Acta crystallographica. Section E, Structure reports online 20080501
Paroxetine. Expert opinion on pharmacotherapy 20080401
Trial registration for public trust: making the case for medical devices. Journal of general internal medicine 20080101
Nutritional therapies for mental disorders. Nutrition journal 20080101
Generic entry, reformulations and promotion of SSRIs in the US. PharmacoEconomics 20080101
[The anxyolytic effect of mild hypobaric hypoxia in a model of post-traumatic stress disorder in rats]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 20080101
Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis. The Journal of clinical psychiatry 20071201
Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG : an international journal of obstetrics and gynaecology 20070901
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clinical therapeutics 20070501
Patterns of prescription and self-medication for treating primary dysmenorrhea in a Mexican population. Proceedings of the Western Pharmacology Society 20070101
Effect of generic-only drug benefits on seniors' medication use and financial burden. The American journal of managed care 20060901
There is no such thing as a psychiatric disorder/disease/chemical imbalance. PLoS medicine 20060701
[Selective serotonin reuptake inhibitors (SSRIs) in pregnancy]. Revue medicale suisse 20060412
Disease mongering in drug promotion: do governments have a regulatory role? PLoS medicine 20060401
Paxil: part of the process. Nature reviews. Drug discovery 20060401
What are the public health effects of direct-to-consumer drug advertising? PLoS medicine 20060301
Paxil and the risk of birth defects. FDA consumer 20060101
The SSRI trials in children: disturbing implications for academic medicine. Ethical human psychology and psychiatry 20060101
Rare case of serotonin syndrome with therapeutic doses of paroxetine. American journal of therapeutics 20060101
Urticarial vasculitis secondary to paroxetine. Journal of drugs in dermatology : JDD 20060101
Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS medicine 20051201
Medicine as a corporate enterprise, patient welfare centered profession, or patient welfare centered professional enterprise? Mens sana monographs 20051101
Damming the flow of drugs into drinking water. Environmental health perspectives 20051001
[Clinical effects of paxil in poststroke rehabilitation]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101
Manufacturing violations prompt seizure of Paxil CR, Avandamet. FDA consumer 20050101
A taxpayer-funded clinical trials registry and results database. PLoS medicine 20041201
Antidepressant medication use among First Nations peoples residing within British Columbia. American Indian and Alaska native mental health research (Online) 20041105
Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environmental toxicology and chemistry 20040901
Environmental risk assessment of paroxetine. Environmental science & technology 20040615
Medicalization, markets and consumers. Journal of health and social behavior 20040101
Causality and collateral estoppel: process and content of recent SSRI litigation. The journal of the American Academy of Psychiatry and the Law 20030101
Concerns about Paxil for children. FDA consumer 20030101
Adolescents searching for health information on the Internet: an observational study. Journal of medical Internet research 20030101
Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 20020917
Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes. The Journal of pharmacology and experimental therapeutics 20011201
Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors. Brain research 20010209
By the way, doctor. I've been taking Paxil for depression for about six months. Although it's helped my symptoms of depression, I've lost interest in sex. Aside from stopping the medication, is there any way to regain my sexual function? Harvard women's health watch 20010201
Paxil and self-scratching. Journal of the American Academy of Child and Adolescent Psychiatry 20010101
[A case of a rare side effects of paxil therapy in a male patient with irritable colon syndrome]. Klinicheskaia meditsina 20010101
New use for Paxil approved. FDA consumer 20010101
[Effect of several neuroleptic, adreno-, sympatho- and cholinolytic substances on the development of experimental cerebral edema induced by nicotine]. Farmakologiia i toksikologiia 19770101
Properties